Image Description (Desvenlafaxine Tablets Figure 1)
Desvenlafaxine Tablet, Extended Release
Product Images NDC 71335-2490
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine (NDC 71335-2490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Desvenlafaxine Tablets Figure 2)
This text provides information on the change in Cmax (maximum plasma concentration) of Ketoconazole due to the interaction with CYP3A4 inhibitors. It includes the geometric mean ratio with 30% confidence intervals for the change relative to the reference, showing the impact of the CYP3A4 inhibitors on the pharmacokinetics of Ketoconazole.*
Image Description (Desvenlafaxine Tablets Figure 3)
Image Description (Desvenlafaxine Tablets Figure 4)
This is a graph presenting the estimated proportion of patients experiencing relapse at different time intervals (in days from randomization) for patients taking Desverla 50mg versus Placebo. The data shows that around 40% of patients experienced relapse at a certain point in time.*
Image Description (Desvenlafaxine Tablets Figure 5)
Estimated proportion of patients with relapse over time (in days from randomization) comparing Desvenlafaxine to Placebo. The chart shows the percentages of relapse at different time intervals.*
Image Description (Desvenlafaxine Tablets Structure)
Label (Lbl713352490)
This text contains information about Desvenlafaxine Extended-Release Tablets. It describes the content of each film-coated tablet, the storage conditions, usage instructions, and a link for further information. It also includes details about the manufacturer and repackager of the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
